![](/img/cover-not-exists.png)
Resistance to gefitinib and cross-resistance to irreversible EGFR-TKIs mediated by disruption of the Keap1-Nrf2 pathway in human lung cancer cells
Park, Seong-Hee, Kim, Jae Hwan, Ko, Eunsun, Kim, Jeong-Yub, Park, Myung-Jin, Kim, Min Jung, Seo, Hyemin, Li, Shibo, Lee, Ji-YunLanguage:
english
Journal:
The FASEB Journal
DOI:
10.1096/fj.201800011R
Date:
May, 2018
File:
PDF, 2.16 MB
english, 2018